Liposomal bupivacaine inferior to indwelling interscalene nerve block for post-operative pain control in shoulder arthroplasty: a prospective randomized controlled trial

2017 ◽  
Vol 26 (5) ◽  
pp. e151
Author(s):  
Jeffrey T. Abildgaard ◽  
Keith T. Lonergan ◽  
Stefan J. Tolan ◽  
Michael J. Kissenberth ◽  
Richard J. Hawkins ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Nerve Block ◽  
Shoulder Arthroplasty ◽  
Pain Control ◽  
Controlled Trial ◽  
Liposomal Bupivacaine ◽  
Randomized Controlled ◽  
Post Operative Pain ◽  
Prospective Randomized Controlled Trial ◽  
Interscalene Nerve Block

scholarly journals Liposomal bupivacaine addition versus standard bupivacaine alone for colorectal surgery: a randomized controlled trial

2021 ◽  
Author(s):  
Yar L Yeap ◽  
John Wolfe ◽  
Jennifer Stewart ◽  
Amy McCutchan ◽  
Gulraj Chawla ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Colorectal Surgery ◽  
Laparoscopic Colorectal Surgery ◽  
Controlled Trial ◽  
Liposomal Bupivacaine ◽  
Randomized Controlled ◽  
Pain Scores ◽  
Quadratus Lumborum ◽  
Prospective Randomized Controlled Trial ◽  
Registration Number

Aim: This study evaluated use of liposomal bupivacaine (LB) versus standard bupivacaine (SB) alone in quadratus lumborum (QL) blocks for laparoscopic colorectal surgery. Materials & methods: In this prospective, randomized controlled trial, patients received QL1 blocks with either LB (40 ml 0.125% SB plus 20 ml of LB) or SB (60 ml of 0.25% SB) with 30 ml per side. Opioid usage, pain scores, side effects and other medications were recorded. Results: For 78 patients (38 LB; 40 SB), all parameters were similar between groups, except that the LB group had a higher 48 h need for metoclopramide. Conclusion: LB provided no analgesic benefit over SB alone for QL blocks. Clinical Trials registration number: NCT03702621

Sign in / Sign up

Export Citation Format

Share Document